Hess, Georg; Dreyling, Martin; Oberic, Lucie et al.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review studyBRITISH JOURNAL OF HAEMATOLOGY. 2022
Lommatzsch, Marek; Suhling, Hendrik; Korn, Stephanie et al.
Safety of combining biologics in severe asthma: Asthma-related and unrelated combinationsALLERGY. Bd. 77. H. 9. 2022 S. 2839-2843
Tilch, Marie-Kristin; Robak, Tadeusz; Ghiggi, Chiara et al.
Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed LymphomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 22. H. 4. 2022 S. 270-275
Panse, Jens; Toelle, Daniela; Fiegle, Eva et al.
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-studyANNALS OF HEMATOLOGY. Bd. 101. H. 10. 2022 S. 2317-2324
Gärtner, J; Gahr, S; Reinholz, U et al.
Sinnvolle Strategien für die Versorgung im DelirDeutsches Ärzteblatt. Bd. 3. 2022 S. 14-17
Tilch, Marie-Kristin; Schranz, Melanie; Moringlane, Alice et al.
Struggling with extensive informed consent procedures for cancer trials-is there even a benefit for the patients?SUPPORTIVE CARE IN CANCER. Bd. 30. H. 8. 2022 S. 6593-6602
Nowakowski, Grzegorz S.; Yoon, Dok Hyun; Joffe, Erel et al.
Subgroup analysis in RE-MIND2, an observational, retrospective cohort study of tafasitamab plus lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Bell, Elisabeth; Desuki, Alexander; Karbach, Susanne et al.
Successful treatment of doxorubicin-induced cardiomyopathy with low-dose sacubitril/valsartan: a case reportEUROPEAN HEART JOURNAL-CASE REPORTS. Bd. 6. H. 10. 2022
Stickdorn, Judith; Stein, Lara; Arnold-Schild, Danielle et al.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsACS NANO. Bd. 16. H. 3. 2022 S. 4426-4443
Agaimy, Abbas; Arbogast, Helmut; Barth, Thomas et al.
Thanks to the Reviewers of The PathologistPATHOLOGE. Bd. 43. H. 1. 2022 S. 3-4